COLO B Coloplast A/S Class B

Coloplast A/S - Allocation of Share Options

Coloplast A/S - Allocation of Share Options

Report on transactions of executives and related parties in Coloplast shares and related securities

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.

The below transactions concern allocation of share options.

For further details, reference is made to Coloplast’s Remuneration Policy which was adopted in 2019. The policy is available on the Group website at this address:

1Details of the person discharging managerial responsibilities/person closely associated
a)NameKristian Villumsen
2Reason for the notification
a)Position/statusPresident & CEO
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0054,102
d)Aggregated information 
-  Aggregated volume54,102 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue



1Details of the person discharging managerial responsibilities/person closely associated
a)NameAnders Lonning-Skovgaard
2Reason for the notification
a)Position/statusExecutive Vice President, CFO
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0027,473
d)Aggregated information 
-  Aggregated volume27,473 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue



1Details of the person discharging managerial responsibilities/person closely associated
a)NamePaul Marcun
2Reason for the notification
a)Position/statusExecutive Vice President, Chronic Care
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0030,407
d)Aggregated information 
-  Aggregated volume30,407 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue



1Details of the person discharging managerial responsibilities/person closely associated
a)NameAllan Rasmussen
2Reason for the notification
a)Position/statusExecutive Vice President, Global Operations
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0025,500
d)Aggregated information 
-  Aggregated volume25,500 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue

  

1Details of the person discharging managerial responsibilities/person closely associated
a)NameLars Rasmussen
2Reason for the notification
a)Position/statusChairman of the Board of Directors
b)Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameColoplast A/S (CVR-no.: 69749917)
b)LEI529900NN7SOJ5QG82X67
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrument Share options relating to B shares
Identification codeISIN: DK0060448595 (B shares)
b)Nature of the transactionShare option allocation
c)Price and volumePriceVolume
0.0014,904
d)Aggregated information 
-  Aggregated volume14,904 share options
-  PriceDKK 0.00
e)Date of the transaction2020-01-20, 14:00 UTC
f)Place of the transactionOutside a trading venue

This information is available in Danish and in English, in case of doubt the Danish version prevails. For further information: Hannah Katrine Larsen, tel.: .

Attachment

EN
20/01/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - Opdateret finanskalender 2025-26

Coloplast A/S - Opdateret finanskalender 2025-26 Venligst se vedlagte pdf.  Opdatering af datoer i finanskalenderen Coloplast har opdateret datoerne i selskabets finanskalender vedrørende offentliggørelsen af årsregnskabet for 2025/26 samt afholdelsen af den ordinære generalforsamling 2026. De opdaterede datoer er som følger: Årsregnskabsmeddelelse for 2025/26 og Årsrapport 2025/26: ændret fra 5. november 2026 til 3. november 2026Ordinær generalforsamling 2026: ændret fra 3. december 2026 til 1. december 2026 For yderligere information og kalenderinvitationer til kommende beg...

 PRESS RELEASE

Coloplast A/S - Updated Financial Calendar 2025-26

Coloplast A/S - Updated Financial Calendar 2025-26 Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General Meeting 2026.  The updated dates are as follows: Financial Statements for the full year 2025/26 and Annual Report 2025/26: changed from November 5, 2026 to November 3, 2026Annual General Meeting 2026: changed from December 3, 2026 to December 1, 2026 For more information and calendar invitations for upcoming events, please visit:   Kind...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch